New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Recent Cholesterol Guidelines and Integration into Clinical Practice

The North American Thrombosis Forum (NATF)

J. Plutzky, L. Braun, J. Ross

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

ACC 2023 Conference Coverage

J. Saseen

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

MAFLD: What Is It?

Houston Methodist

D. Victor

How Do I Reverse Coronary Plaque?

Scripps Health

C. J. Suhar

Medical Management of Metabolic Associated Steatotic Liver Disease

Michigan Medicine

R. Fontana

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Scripps Health

N. Lepor

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "Go as…

ACC 2022 Conference Coverage

R. Giugliano

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Piedmont Heart Institute

A. Klein

VICTORION-INITIATE – Comparing Inclisiran First to Usual Care in Pat…

Canadian Collaborative Research Network

M. Gupta

Inside the Studio with Drs. Joseph Rogers and Salim Virani - Current…

The Texas Heart Institute

J. Rogers, S. Virani

Statin & Warfarin Induce Accelerated Atherosclerosis and Are Contra-…

CVC 2018

ACC 2022: How I Manage Statin-associated Muscle Symptoms and Other B…

ACC 2022 Conference Coverage

P. Toth

Update on Lipids: Current Options for Lowering LDL to Reduce CV Risk

Jefferson Health

A. Cohen

Big Questions About Lipoprotein “Little” (a)

MUSC Cardiology

A. Arana Waring

NLA Scientific Statement on Statin Intolerance: A New Definition and…

National Lipid Association

M. Cheeley